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Background: Dyslipidemia is one of the most important independent modifiable risk factors for cardiovascular
diseases. The objective of this study was to determine the prevalence and risk factors for dyslipidemia in Shenzhen,
a special economic zone and large metropolitan area neighboring Hong Kong.
Methods: A cross-sectional survey of 1,995 adults with a mean age of 46.56 years was conducted between February
and July 2011 using a multistage stratified cluster random sampling. All the subjects were administered questionnaires
regarding socio-demographic characteristics and other possible factors associated with the prevalence of dyslipidemia.
Fasting venous blood samples were collected to assess the lipid profile. Weight, height, waist circumference, and blood
pressure were measured.
Results: The mean concentrations of total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol
(HDL-C), and low density lipoprotein cholesterol (LDL-C) were 5.11 ± 1.15 mmol/L, 1.59 ± 1.47 mmol/L, 1.42 ± 0.33 mmol/L,
and 3.22 ± 0.84 mmol/L, respectively. High values of TC, TG, low HDL-C, and high LDL-C were obtained in
14.49 %, 16.14 %, 8.82 %, and 12.13 % of the 1,995 participants, respectively. The prevalence of dyslipidemia was
34.64 %, among which 25.04 % of subjects were aware. Presence of dyslipidemia was significantly associated with
increasing age, smoking status, hypertension, diabetes, and body mass index.
Conclusions: High prevalence of dyslipidemia with relative low awareness in Shenzhen was found. A comprehensive
strategy is required for the prevention, screening, treatment, and control of dyslipidemia in Shenzhen.
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Dyslipidemia is defined as the derangements of one or
more of the lipoproteins in blood, such as elevated in
total cholesterol (TC), low density lipoprotein choles-
terol (LDL-C) and/or triglycerides (TG), or low levels of
high density lipoprotein cholesterol (HDL-C) alone [1].
The results of other studies suggested that many persons
with dyslipidemia were overtly under-diagnosed and it is
estimated that prevalent cases of dyslipidemia in the
nine major countries will increase at the rate of 1.76 %
per year to surpass 500 million in 2022 [2]. The number
of people with dyslipidemia is expected to reach 78 mil-
lion in the major countries by 2022, of which, one sixth
of all cases will occurre in China [2]. The prevalence of
dyslipidemia is high and increases continuously in many* Correspondence: anniexu73@126.com
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diet, obesity, aging of population, reduced physical activ-
ity, and other adverse lifestyle changes [3]. Dyslipidemia
is one of the most important and modifiable risk factors
for cardiovascular diseases, which is also a major cause
of morbidity and leads to mortality worldwide [4]. The
morbidity and mortality of cardiovascular diseases in
China are expected to increase both in absolute number
and as a proportion of total disease burden, parallel
changes in lifestyle and diet in the next 20 years [5].
Several clinical trials have indicated that the treatment
of dyslipidemia is effective in both primary and second-
ary prevention of cardiovascular events [6, 7]. Treatment
of dyslipidemia can reduce the risk of heart disease by
approximately 30 % over a 5-year period [8]. Neverthe-
less, surveys in China have showed poor awareness, treat-
ment and control of dyslipidemia [9, 10]. In order to
improve dyslipidemia control, it is critical to understanddistributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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fore, new initiatives and resources can be targeted and
tailored to the needs of high-risk populations. Studies con-
ducted in different regions of China have measured
relationships between potential risk factors and dyslipid-
emia, however, differences in socioeconomic status, demo-
graphic composition, lifestyle, dietary, alcohol intake, and
physical activity in Shenzhen suggest the necessity of ree-
valuating these factors in Shenzhen’s current context [11,
12]. Therefore, the primary goal of present study was to
investigate the prevalent status of dyslipidemia in a repre-
sentative sample of the urban population aged more than
20 years that includes 12 streets from 8 districts of the city
of Shenzhen, and its association with other risk factors.
Materials and methods
Sampling sites
As China’s first Special Economic Zone to spur eco-
nomic growth after the near collapse of the socialist
centrally-planned economy in 1978, Shenzhen has trans-
formed from an agriculture-based Baoan County into a
21st century metropolis housing over millions of people.
Unprecedented social and economic development in
Shenzhen has led to changes in patterns of diet, physical
activity, and other socio-demographic characteristics
that are contributing to large increases in the prevalence
of cardiovascular disease and other chronic diseases
[13]. Dyslipidemia is a well known risk factor for cardio-
vascular disease. A prevention measure against the epi-
demic of dyslipidemia will undoubtedly push down the
morbidity and mortality of cardiovascular diseases. The
associated factors of dyslipidemia in Beijing, Shaoxing,
and Delhi has have been evaluated; however, little data
are available in Shenzhen [11, 12, 14].
The present study was conducted as a part of the
China Health and Nutrition Survey at the Center for
Chronic Disease Control of Shenzhen. In brief, the sur-
vey used a multistage stratified cluster random sampling
method to select a representative sample of permanent
residents in 8 different districts in Shenzhen city. The
first stage of sampling was stratified by district and
population distribution on the basis of Shenzhen popula-
tion data from 2010, which involved the random selec-
tion of 12 streets from those 8 districts. In the second
stage, one residential community was randomly selected
from each selected street. In the third stage, about 75
households were randomly selected from the residential
communities selected in the earlier stage. In the last
stage, eligible family member from each designated
household was chosen.
Study population
Volunteers were recruited from selected households
from February 2011 to July 2011. The eligibility criteriawere set as following: aged 20 years or above, living in
Shenzhen for more than 5 years, men or non-pregnant
women, confirmed not to present with cancer, severe
liver disease, pancreatitis, polycystic ovarian syndrome,
systemic lupus erythematosus, and kidney diseases.
From February 2011 to July 2011, 1,995 participants
were recruited according to the eligibility criteria. All
participants received information and publicity about
the health risk that may result from dyslipidemia expos-
ure. All participants have the chances to receive the
health check and biochemical determination results if
they provided their telephone number or other contact
information. The study received ethnicity approval of
the Center for Chronic Disease Control of Shenzhen.
Written informed consent was obtained from all partici-
pants before the study.
Questionnaire survey
Structured questionnaires were administered to collect
information on potential risk factors for elevated blood
lipids, as well as possible factors associated with dyslip-
idemia. Volunteers were interviewed in person 1 to
2 hours after blood collection and each questionnaire
took approximately 20 min to complete. Questions cov-
ered general information (age, gender, ethnic, place of
residence, employment and marital status), socioeco-
nomic status (household per capita income and educa-
tion level), health behaviors (drinking habit, level of
physical activity, and smoking habit), and personal med-
ical history.
The age groups were classified according to results
from Shenzhen 2010 census as 20 to 29 years, 30 to
39 years, 40 to 49 years, 50 to 59 years, 60 to 69 years,
69 to 79 years, and ≥80 years. Employment status was
classified into one of the followings: homemaker,
employed, unemployed, retired, and others. Marital sta-
tus was categorized as single, married, widowed, and di-
vorced. Educational level was categorized into 5 groups
according to the number of years of education (0, 1–6, 7–
9, 10–12, and ≥12 years). Subjects were asked to choose 1
of 10 income categories that best represented the house-
hold per capita income for the past 12 months: < 5,000
RMB; 5,000 to 9,999 RMB; 10,000 to 14,999 RMB; 15,000
to 19,999 RMB; 20,000 to 24,999 RMB; 25,000 to 29,999
RMB; 30,000 to 34,999 RMB; 35,000 to 39,999 RMB; ≥
40,000 RMB; and unclear. The questions regarding
smoking, which are described in details elsewhere, per-
mit stratification of participants into categories such as
ever-smokers (including: current smokers and ex-smokers)
and never smokers [15]. Participants were also defined as
habitual drinker (drink once per day or more), non-
habitual drinker (six times per week to once per month),
or non-drinker (almost never) [16]. In the survey, the term
“moderate to vigorous intensity physical activity” was
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and shortness of breath, whereas the term “light physical
activity” was defined as causing no sweating or shortness
of breath [17]. Furthermore, physical activity was defined
as moderate to vigorous intensity physical activity not less
than once a week.
Physical examination
Anthropometric examinations were administered in the
morning after fasting overnight, followed by body mea-
surements, which were taken by trained examiners using
a standardized protocol. Height, body weight, waist cir-
cumference, and blood pressure of all participants were
recorded. Height and weight were measured with the
participants wearing light dress without shoes using ana-
log scales. Waist circumference (WC) was measured at
the midpoint level of midaxillary line between the 12th
rib head and the superior anterior iliac spine, with meas-
uring time at the end of normal expiration. Body mass
index (BMI) was calculated by dividing body weight (in
kilograms) by the square meters of height. Blood pres-
sure was measured using a mercury sphygmomanometer
on the right arm of each of the participants in a com-
fortable sitting position after a 30 min rest period. Three
consecutive blood pressure measurements were per-
formed, and the mean of these three measurements was
applied in the subsequent analysis.
Blood sample collection and analyses
Vein blood samples were collected after 10 to 14 hours
of fasting. Each glass automatic hemostix was marked
with the volunteer’s identification code and placed into
ice in a portable refrigerator before transporting to la-
boratory. In our laboratory, the blood samples were sep-
arated by centrifugation at 1000 × g for 15 min at 4 °C,
and then supernatant serum was collected. Serum glu-
cose (fasting blood glucose), TC, TG, LDL-C, and HDL-
C concentrations were measured by using commercially
available kits (Olympus System Reagents, Olympus Diag-
nostica GmbH, Clare, Ireland) by autoanalyzer (Olympus
AU400 System, Olympus, Tokyo, Japan). Serum TG were
measured using the glycerol-3 phosphate oxidase-phenol
+ 4-aminophenazone enzymatic colorimetric method and
TC by the cholesterol oxidase method. HDL-C was esti-
mated in a series of reaction steps using an enzymatic
cholesterol reagent after precipitation of non–HDL-C with
magnesium/dextran, and LDL-C was estimated using a
third-generation direct LDL cholesterol assay. The labora-
tory variation coefficient of TC, TG, HDL-C, and LDL-C
was 1.5 %, 4.3 % , 3.0 %, and 3.9 %, respectively (indi-
cating that long term standardization of TC, TG, HDL-C
and LDL-C can be obtained with automated enzymatic
methods utilizing commercially available reagents). Fur-
thermore, as measures of quality control and assurance,analytical duplicates, and reagent blanks were routinely in-
cluded in the analytical sequence for detection of precision
and signs of contamination, respectively. In all cases, ana-
lyses were performed after the correct values had been
confirmed by the instrument. All blood samples were ana-
lyzed within 4 hours after being collected.Definitions of dyslipidemia, obesity, diabetes and
hypertension
Dyslipidemias were defined according to Chinese criteria
[18]. High TC was defined as a TC value ≥6.22 mmol/L
and hypertriglyceridemia (high TG) was defined as a
serum TG level ≥2.26 mmol/L. Low HDL-C was defined
as a serum HDL-C level <1.04 mmol/L. High LDL-C
was defined as a serum LDL-C level ≥4.14 mmol/L. In
the present study, high TC, and/or high LDL-C, and/or
low HDL-C and/or high TG, and/or having a history of
dyslipidemia disease in the past year, and/or currently
receiving treatment with lipid-lowering medications was
regarded as dyslipidemia. Awareness of dyslipidemia was
defined as answering “yes” to the following question:
“During the past year, has a healthcare professional told
that you had dyslipidemia?”.
Body mass index (BMI) was used as a measure of body
size. Participants with BMI <18.5 kg/m2 were classified
as underweight, those with BMI of 18.5 to 23.9 kg/m2 as
normal weight, those with BMI of 24 to 27.9 kg/m2 as
overweight, and those with BMI of ≥28 kg/m2 as obese
[19]. Two sets of cut offs were used to define central obes-
ity in terms of waist circumference. These were >95 cm
for men and >90 cm for women on the basis of specific
guidelines for central obesity [19].
Hypertension was defined as mean systolic blood
pressure ≥140 mmHg and/or diastolic blood pres-
sure ≥90 mmHg, and/or self-reported antihypertension
treatment in the last 2 weeks. Diabetes was defined as
fasting blood glucose (FBG) ≥7.0 mmol/L, and/or self-
reported treatment of diabetes with antidiabetes medi-
cation in the previous 2 weeks.Statistical analyses
The mean and standard deviation of continuous vari-
ables were expressed as mean ± SD, and percentage was
calculated for categorical variables. Age and other an-
thropometric examination characteristic differences be-
tween groups defined by gender were evaluated using
Student's t-test. The chi-squared test or Fisher’s exact
test was used to determine significant differences in pro-
portions among categorical variables. Normal distribu-
tion of the serum lipid concentration was tested by
Kolmogorov-Smirnov test, and showed a highly skewed.
Changes in outcome measures between the different
groups not following normal distribution were tested by
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pendent variables.
The univariate and multivariate logistic regression
models were used to investigate the probability to
having dyslipidemia according to socio-demographic
and other variables. Statistical analysis of the data was
performed by Statistical Package for Social Sciences
(SPSS) version 21.0 software (SPSS Inc., Chicago, IL,
USA). A P value of <0.05 was considered to be statis-
tically significant. We estimated age standardizedTable 1 Socio-demographic and other characteristics of participants
Characteristics General (n = 1995) Women (n
Age (years) 46.56 ± 15.26 46.07 ± 15.0
BMI (Kg/m2) 23.52 ± 3.49 23.21 ± 3.47
SBP (mm Hg) 115.65 ± 17.58 113.92 ± 18
DBP (mm Hg) 74.97 ± 10.11 73.16 ± 10.0
WC (cm) 82.04 ± 10.51 79.16 ± 10.1
FBG (mmol/L) 5.39 ± 1.32 5.28 ± 1.13
Physical activity, n (%)
Yes 1591 (79.75) 979 (88.19)
No 404 (20.25) 131 (11.81)
Smoking status, n (%)
Ever smoker 414 (20.75) 10 (0.90)
Never smoker 1581 (79.25) 1100 (99.10
Drinking habit, n (%)
Non-drinker 1295 (64.91) 887 (79.91)
Non-habitual drinker 586 (29.37) 192 (17.30)
Habitual drinker 114 (5.72) 31 (2.79)
Marital status, n (%)
Single 129 (6.47) 69 (6.22)
Married 1771 (88.77) 962 (86.67)
Widowed 25 (1.25) 21 (1.89)
Divorced 70 (3.51) 58 (5.22)
Educational level, n (%)
0 year 73 (3.66) 63 (5.68)
1–6 years 261 (13.08) 172 (15.50)
7–9 years 524 (26.26) 286 (25.77)
10–12 years 855 (42.86) 475 (42.79)
≥12 years 282 (14.14) 114 (10.26)
Employment status, n (%)
Unemployed 92 (4.61) 56 (5.05)
Retired 487 (24.41) 262 (23.60)
Others 156 (7.82) 77 (6.94)
Homemaker 297 (14.89) 269 (24.23)
Employed 963 (48.27) 446 (40.18)
Data are expressed as mean ± SD if not indicated.
BMI Body mass index, FBG Fasting blood glucose, WC Waist circumferenceprevalence rate, and the standard population used in
the direct method was the Shenzhen 2010 census
population.
Results
Socio-demographic and other characteristics of
participants
The Socio-demographic and other characteristics of the
participants are summarized in Table 1. Of the 1,995
participants, 44.36 % (n = 885) were men, 55.64 % (n =in the study
= 1110) Men (n = 885) Statistics P
5 47.17 ± 15.53 t = 1.594 0.111
23.89 ± 3.46 t = 4.320 <0.001
.31 117.81 ± 16.36 t = 4.993 <0.001
6 77.24 ± 9.71 t = 9.140 <0.001
4 85.67 ± 9.83 t = 14.438 <0.001
5.52 ± 1.52 t = 3.937 <0.001
612 (69.15) χ2 = 110.599 <0.001
273 (30.85)
404 (45.65) χ2 = 599.570 <0.001
) 481 (54.35)
408 (46.10) χ2 = 248.308 <0.001
394 (44.52)
83 (9.38)
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(20-96) years, 83.26 % attained a junior high school or
higher education, 88.77 % were married, and 48.27 %
were employed. The rate of smoking was 20.75 %, and
drinking was 35.09 %, and 79.75 % of the study subjects
reported having regular physical activities. In terms of
anthropometric, the mean levels of average BMI, SBP,
DBP, WC and FBG for all 1,995 participants were
23.52 ± 3.49 Kg/m2, 115.65 ± 17.58 mm Hg, 74.97 ±
10.11 mm Hg, 82.04 ± 10.51 cm, and 5.39 ± 1.32 mmol/
L, respectively.
Significant differences were found in different gender
groups for BMI, SBP, DBP, WC, FBG, physical activity,
smoking status, drinking habit, marital status, educa-
tional level, and employment status (Table 1). Subjects
were examined for the presence of diabetes and hyper-
tension. Approximately 8.78 % of participants suffered
from diabetes and one fifth of subjects (22.31 %) suffer-
ing from hypertension (Table 2). Using BMI as the an-
thropometric indicator, the prevalence of overweight and
obesity among the 1,995 participants were 32.03 % and
10.33 %, respectively (Table 2).Table 2 Relationships between related factors and levels of TG, TC,
Variables TC TG
n Median Range n Median R
Gender
Men 885 5.09 0.94–14.58 885 1.36*** 0.
Women 1110 4.95 0.86–13.35 1110 1.12 0.
Diabetes
Yes 175 5.18* 1.02–10.49 175 1.56*** 0.
No 1820 4.99 0.86–14.58 1820 1.20 0.
Hypertension
Yes 445 5.34*** 1.49–13.35 445 1.57*** 0.
No 1550 4.93 0.86–14.58 1550 1.14 0.
Body size
Underweight 123 4.51*** 0.87–9.44 123 0.93*** 0.
Normal weight 1027 4.89 0.86–14.58 1027 1.05 0.
Overweight 639 5.21 0.94–9.99 639 1.52 0.
Obese 206 5.31 1.49–9.14 206 1.80 0.
Age groups (years)
20–29 269 4.51*** 0.86–9.57 269 0.96*** 0.
30–39 545 4.80 0.87–14.58 545 1.10 0.
40–49 434 5.07 1.02–9.44 434 1.27 0.
50–59 316 5.42 0.94–9.31 316 1.40 0.
60–69 251 5.40 5.40–10.49 251 1.46 0.
70–79 150 5.28 1.36–13.35 150 1.34 0.
≥80 30 5.46 2.77–7.94 m 1.20 0.
*: P < 0.05; **: P < 0.01; ***: P < 0.001
TC Total cholesterol, TG Triglycerides, HDL-C High density lipoprotein cholesterol, LDSerum lipid concentrations
The mean concentrations of TC, TG, HDL-C, and
LDL-C were 5.11 ± 1.15 mmol/L, 1.59 ± 1.47 mmol/L,
1.42 ± 0.33 mmol/L, and 3.22 ± 0.84 mmol/L, respect-
ively, in the general Shenzhen population aged from 20
to 96 years.
There were significant differences in TG, HDL-C,
and LDL-C concentrations between men and women,
whereas the mean concentration of TC was similar in
both genders (P = 0.083). In addition, we found that
serum lipid concentrations were significantly positively
(including: TC, TG, LDL-C) or negatively (HDL-C) cor-
related to diabetes, hypertension, body size, and age
(Table 2).
Prevalence of dyslipidemia components
In this study, 31.88 % of the study population showed at
least one abnormal lipid parameter. When analyzing for
dyslipidemia components, a hypercholesterolemia was
found in 14.49 %, a hypertriglyceridemia in 16.14 %, an
elevated levels of low density lipoprotein cholesterol in
12.13 %, and abnormally low high density lipoproteinHDL-C and LDL-C in serum samples (mmol/L)
HDL-C LDL-C
ange n Median Range n Median Range
34–21.83 885 1.28*** 0.41–5.24 885 3.26*** 0.43–7.06
25–10.56 1110 1.47 0.62–4.51 1110 3.07 0.87–7.38
47–21.83 175 1.25*** 0.68–2.28 175 3.32** 1.30–6.50
25–21.22 1820 1.39 0.41–5.24 1820 3.14 0.43–7.38
47–11.47 445 1.32*** 0.60–2.41 445 3.44*** 1.06–7.38
25–21.83 1550 1.40 0.41–5.24 1550 3.07 0.43–7.06
25–3.77 123 1.56*** 1.01–2.72 123 2.63*** 1.26–6.89
27–21.83 1027 1.46 0.41–5.24 1027 3.03 0.43–7.38
41–20.38 639 1.30 0.63–2.29 639 3.36 1.06–6.99
53–13.99 206 1.23 0.60–2.06 206 3.44 1.59–6.43
33–13.99 269 1.43** 0.74–2.60 269 2.68*** 1.26–6.80
25–21.22 545 1.37 0.74–5.24 545 2.99 0.43–7.06
27–20.38 434 1.34 0.41–2.66 434 3.17 1.25–8.89
40–11.21 316 1.41 0.63–2.71 316 3.45 1.30–6.99
53–21.83 251 1.37 0.62–4.51 251 3.50 1.56–6.50
47–4.71 150 1.35 0.83–2.31 150 3.42 2.00–7.38
48–7.36 30 1.37 1.00–2.12 30 3.33 1.06–6.18
L-C Low density lipoprotein cholesterol
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Almost one sixths of the study participants (15.99 %)
showed more than one abnormal lipid fractions, and in
4 subjects deranged levels of all four lipid fractions was
found (data not shown).
The prevalence of dyslipidemia components according to
gender, age, body size, and other characteristics is provided
in Table 4. Higher hypertrigylceridemia prevalence was
found among those men who were ever smoker, central
obesity, overweight and obese, and older. The prevalence of
high TC, high LDL-C, and low HDL-C was significantly
high in those with abnormal body weight. The prevalence
of high TC was significantly high among the respondents
with alcohol drinking and the aged. The prevalence of low
HDL-C was found to be significantly high in men, ever
smoker, and those with central obesity, whereas the preva-
lence of high LDL-C was significantly associated with age.
Prevalence and influencing factors of dyslipidemia
Dyslipidemia was found for 636 (31.88 %) of the partici-
pants. A positive history of dyslipidemia disease in the
past year, and/or currently receiving treatment with
lipid-lowering medications was described by 55 subjects,
so that the total prevalence of dyslipidemia was 34.64 %.
Adjusted for age on the basis of Shenzhen census 2010,
the prevalence of dyslipidemia was 25.98 %. This repre-
sents 2.2 million Shenzhen adults aged from 20 to 96 years
with dyslipidemia. Among subjects with dyslipidemia,Table 3 Proportion (95 % confidence interval) of concentrations cla


















TC Total cholesterol, TG Triglycerides, HDL-C High density lipoprotein cholesterol, LD173(25.04 %) were aware of the diagnosis of their
condition.
A number of potential independent factors that might
influence the prevalence of dyslipidemia were evaluated
by univariate logistic regression model. The results re-
vealed that the variables of gender, diabetes, hyperten-
sion, central obesity, smoking status, body size, marital
status, educational level, employment status, household
per capita income (data not shown), and age were sig-
nificantly associated with the prevalence of dyslipidemia
(Table 5). On the contrary, the prevalence of dyslipid-
emia was found not to be significantly higher in non-
habitual drinkers and habitual drinkers, and exercisers.
In order to further evaluate the main factors contributed
to the prevalence of dyslipidemia and control potential
confounding factors, multiple stepwise regression ana-
lyses were also performed. Stepwise multiple regression
analysis revealed that the presence of dyslipidemia was
still significantly associated with increasing age, diabetes,
hypertension, body size, and smoking status (Table 6).
With regard to health status, participants with diabetes
had a 1.498 fold increased prevalence of dyslipidemia
(P = 0.022), and participants with hypertension had
1.595 fold increased prevalence of dyslipidemia (P <0.001).
With regard to health behaviors, ever smokers more likely
to had dyslipidemia (OR = 2.033, P < 0.001). Evaluation
of body size suggested that, participants with high body
size had a greater prevalence of dyslipidemia (over-
weight: OR = 3.433, P < 0.001; obese: OR = 4.405, P <ssification of TC, TG, HDL-C and LDL-C in Shenzhen adults
Men Women
53.22 (49.9–56.5) 58.56 (55.6–61.4)
33.00 (29.9–36.1) 26.39 (23.9–29.0)
13.78 (11.6–16.2) 15.05 (13.0–17.2)
63.28 (60.1–66.4) 75.95 (73.4–78.4)
14.91 (12.7–17.4) 12.43 (10.6–14.5)
21.81 (19.2–24.6) 11.62 (9.8–13.6)
14.24 (12.0–16.6) 4.50 (3.4–5.8)
68.47 (65.4–71.5) 57.03 (54.1–59.9)
17.29 (14.9–19.9) 38.47 (35.6–41.4)
55.25 (52.0–58.5) 63.42 (60.6–66.2)
32.66 (29.6–35.8) 24.42 (21.9–27.0)
12.09 (10.1–14.3) 12.16 (10.3–14.2)
L-C Low density lipoprotein cholesterol
Table 4 The prevalence of dyslipidemia components
Characteristics N High TC High TG Low HDL-C High LDL-C
n (%) n (%) n (%) n (%)
Gender
Men 885 122 (13.78) 193 (21.81) *** 126 (14.24) *** 107 (12.09)
Women 1110 167 (15.05) 129 (11.62) 50 (4.50) 135 (12.16)
Smoking status
Ever smoker 414 65 (15.70) 109 (26.33) *** 66 (15.94) *** 52 (12.56)
Never smoker 1581 224 (14.17) 213 (13.47) 110 (6.95) 190 (12.02)
Central obesity
Yes 279 45 (16.13) 85 (30.47) *** 44 (15.77) *** 41 (14.69)
No 1716 244 (14.22) 237 (13.81) 132 (7.69) 201 (11.71)
Drinking habit
Non-drinker 1295 118 (9.11) ** 203 (15.68) 109 (8.42) 165 (12.74)
Non-habitual drinker 586 83 (14.16) 93 (15.87) 60 (10.24) 65 (11.09)
Habitual drinker 114 18 (15.80) 26 (22.81) 7 (7.02) 12 (10.53)
Body size
Underweight 123 17 (13.82) ** 2 (1.63) *** 1 (0.81) *** 13 (10.57) ***
Normal weight 1027 118 (11.49) 93 (9.06) 50 (4.87) 87 (8.47)
Overweight 639 118 (18.47) 158 (23.62) 84 (13.15) 111 (17.37)
Obese 206 36 (17.48) 69 (30.53) 41 (19.90) 31 (15.05)
Age groups (years)
20–29 269 17 (6.32) *** 18 (6.69) *** 17 (6.32) 15 (5.58) ***
30–39 545 48 (8.81) 87 (15.96) 55 (10.09) 35 (6.42)
40–49 434 51 (11.75) 75 (17.28) 38 (8.76) 43 (9.91)
50–59 316 73 (23.10) 61 (19.30) 32 (10.12) 59 (18.67)
60–69 251 57 (22.71) 55 (21.91) 23 (9.16) 52 (20.63)
70–79 150 35 (23.33) 23 (15.33) 10 (6.67) 31 (20.67)
≥80 30 8 (26.67) 3 (10.00) 1 (3.33) 7 (23.33)
*: P < 0.05; **: P < 0.01; ***: P < 0.001
TC Total cholesterol, TG Triglycerides, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol
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age, those who were 50 to 59 years of age had a greater
prevalence of dyslipidemia (OR = 3.012, P < 0.001).
Discussions
With economic growth and adverse changes in lifestyle
(such as a high intake of dietary saturated fat, physical in-
activity and smoking), cardiovascular diseases have become
the leading cause of death in China [20]. Dyslipidemia is
one of the most important independent modifiable risk fac-
tors for cardiovascular diseases. A prevention measure
against the epidemic of dyslipidemia will undoubtedly de-
press the morbidity and mortality of cardiovascular diseases.
This study was conducted in 8 districts of Shenzhen to
comprehensive assess the prevalence of dyslipidemia as
well as the associated risk factors. Our results indicated
that the prevalence of high TC, high TG, high LDL-C,
and low HDL-C were 14.49 %, 16.14 %, 12.13 %, and8,82 %, respectively. It was also revealed that the preva-
lence of dyslipidemia was about 34.64 % (standardized
rate per 2010 Shenzhen population: 25.98 %). Further-
more, our results suggested that the presence of dyslip-
idemia was significantly associated with age, diabetes,
hypertension, body size, and smoking status.
Several previous epidemiological studies reported serum
lipid concentrations in Chinese populations [9, 21, 22]. In
those studies, the China National Diabetes and Metabolic
Disorders Study measured serum lipids in a nationally rep-
resentative sample of 47,352 Chinese aged 20 years or
above and provided the best comparison data for our
study [22]. When compared with the findings from the
China National Diabetes and Metabolic Disorders Study,
the mean levels of TC (5.11 mmol/L vs 4.72 mmol/L), TG
(1.59 mmol/L vs 1.57 mmol/L), HDL-C (1.42 mmol/L vs
1.30 mmol/L), and LDL-C (3.22 mmol/L vs 2.68 mmol/L)
in this study did subtle changes [22]. Also other regional
Table 5 Univariate logistic regression analysis of socio-
demographic and lifestyle factors associated with dyslipidemia
Characteristics OR (95 % CI) P value
Gender 1.719 (1.427–2.070) <0.001
Diabetes 2.502 (1.829–3.423) <0.001
Hypertension 2.818 (2.271–3.498) <0.001
Central obesity 2.280 (1.765–2.944) <0.001
Physical activity 1.057 (0.841–1.328) 0.634
Smoking status 1.923 (1.543–2.397) <0.001
Drinking habit
Non-drinker 1 (reference)
Non-habitual drinker 1.013 (0.825–1.244) 0.901
Habitual drinker 1.025 (0.686–1.532) 0.902
Body size
Underweight 1 (reference)
Normal weight 1.613 (0.979–2.660) 0.061
Overweight 4.914 (2.970–8.129) <0.001
Obese 6.382 (3.674–11.084) <0.001
Marital status
Single 1 (reference)
Married 2.139 (1.376–3.325) 0.001
Divorced 2.641 (1.065–6.551) 0.036
Widowed 3.741 (1.980–7.069) <0.001
Educational level
≥12 years 1 (reference)
10–12 years 0.974 (0.728–1.304) 0.860
7–9 years 1.417 (1.042–1.928) 0.026
1–6 years 1.557 (1.094–2.217) 0.014
0 year 2.064 (1.222–3.487) 0.007
Employment status
Employed 1 (reference)
Homemaker 1.263 (0.958–1.666) 0.098
Others 1.390 (0.976–1.981) 0.068
Retired 2.074 (1.655–2.599) <0.001
Unemployed 0.901 (0.558–1.456) 0.671
Age groups (years)
20–29 1 (reference) <0.001
30–39 1.944 (1.346–2.808) <0.001
40–49 2.333 (1.602–3.396) <0.001
50–59 4.325 (2.938–6.367) <0.001
60–69 4.301 (2.875–6.434) <0.001
70–79 4.020 (2.559–6.316) <0.001
≥80 3.707 (1.685–8.159) 0.001
Table 6 Multivariate stepwise logistic regression analysis of
factors associated with dyslipidemia
Characteristics OR (95 % CI) P value
Diabetes
No 1 (reference)
Yes 1.498 (1.061–2.114) 0.022
Hypertension
No 1 (reference)
Yes 1.595 (1.234–2.060) <0.001
Smoking status
Ever smoker 1 (reference)
Never smoker 2.033 (1.604–2.577) <0.001
Body size
Underweight 1 (reference)
Normal weight 1.280 (0.763–2.147) 0.351
Overweight 3.433 (2.033–5.798) <0.001
Obese 4.045 (2.267–7.215) <0.001
Age groups (years)
20–29 1 (reference)
30–39 1.747 (1.189–2.567) 0.004
40–49 1.761 (1.184–2.618) 0.005
50–59 3.012 (1.989–4.563) <0.001
60–69 2.880 (1.860–4.460) <0.001
70–79 2.722 (1.657–4.471) <0.001
≥80 2.280 (0.974–5.339) 0.058
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local residents. Wang and co-researchers reported that the
mean levels of TC, TG, HDL-C, and LDL-C in Beijing
were 5.05 mmol/L, 1.53 mmol/L, 1.50 mmol/L, and
3.27 mmol/L, respectively [23]. Wu et al. reported that the
mean levels of TC, TG, and HDL-C in Shanghai were
4.70 mmol/L, 1.50 mmol/L, and 1.40 mmol/L, respectively
[24]. Our results were similar to those of the above men-
tioned studies.
During the past several decades, favorable trends in
lipid levels have occurred among adults in the United
States [25]. For example, the mean levels of TC de-
clined from 206 to 196 mg/dL between 1988 to 1994
and 2007 to 2010. Additionally, the mean concentra-
tions of LDL-C declined from 129 to 116 mg/dL during
1988-1994 and 2007–2010. On the contrary, compared
to the result from the 2002 China National Nutrition
and Health Survey, unfavorable trends in lipid levels
have occurred among adults in Shenzhen [26]. It is in
consistent with the general increase in the mean levels
of serum lipid (including: TC, TG, LDL-C) in China
with the increasing urbanization and changes in life-
style [22]. These findings showed important public
health implications, which might explain the recent
Ni et al. Lipids in Health and Disease  (2015) 14:71 Page 9 of 11rapid increase in cardiovascular disease burdens in
Shenzhen [13].
The prevalence of high TC (14.49 %) and high LDL-C
(12.13 %) found in this study were significantly higher
than average Chinese national standards (9.0 % and
6.5 %, respectively), whereas the prevalence of low HDL-
C (8.82 %) was significantly lower than the national aver-
age (22.30 %) [22]. High TC is one of the common lipid
disorders in western countries. With the economic
growth and the increasing popularity of western foods in
Shenzhen, an increasing number of people have changed
their dietary patterns. For example, they may choose to
consume a more westernized diet, which is high in fat
and cholesterol. Therefore, it may be the main contribu-
tor to the high TC in Shenzhen. Compared with studies
carried out in some other regions, the prevalence of dys-
lipidemia components in Shenzhen were lower than
those in Shanghai [24], Delhi [14], and Turkish [1], but a
higher prevalence of high TC or high TG, and lower
prevalence of high LDL-C or low HDL-C were found in
Shenzhen than in Shaoxing [12]. The reported prevalence
of dyslipidemia components varied among Shenzhen,
Shanghai, Delhi, Turkish and Shaoxing, depending on the
information available for the given population and the
diagnostic criteria used. In the present study, the most
prevalent component of dyslipidemia was the increased
TG with a prevalence of 16.14 %. A similar study reported
that the most prominent change in serum lipids in Beijing
and Guangzhou over the past 20 years was the increase in
serum TG levels, which were dramatically influenced by
the increased consumption of diets high in simple carbo-
hydrates and fat [27]. However, other studies found that
the major types of dyslipidemia in China and other Asian
countries are low HDL-C [24, 28, 29], whereas high TC as
the most common lipid disorder in Western countries [1].
The prevalence of dyslipidemia in our study was par-
tially comparable to figures reported in previous epi-
demiological studies [10, 12, 24]. For example, in a cross
sectional study with a representative sample of 5,761
Chinese adults aged from 18 to 79 years, 35.40 % of the
subjects had dyslipidemia [10]. In addition, in a recent
study on 11,877 Shaoxing residents aged 20 years or
older, the age standardized prevalence of dyslipidemia
was 25.80 % (the age standardized dyslipidemia preva-
lence in Shenzhen was 25.98 %) [12]. Our results, to-
gether with other study, confirmed that the prevalence
of dyslipidemia is increasing in Shenzhen [22, 26]. Not-
ably, the rate of awareness documented in this survey is
lower than those recently reported from cross sectional
study conducted in Beijing, and elsewhere during the
same periods [30, 31]. It is obviously that Shenzhen is
going to experience a large increase in the prevalence of
cardiovascular disease, if reasonable and effective control
measures not taken.Previous studies reported that age did appear to influ-
ence dyslipidemia risk [1, 11, 12, 14, 24]. In the present
study, compared with participants aged from 20 to
29 years, those who were 50 to 59 years of age had a
greater prevalence of dyslipidemia. With the aging popu-
lation trend in China, the picture of the public health
posed by dyslipidemia will be aggravated. However, the
precise mechanisms of the effect of age on serum lipid
concentrations are not exactly known—they may be re-
lated to hereditary characteristics and degenerative pro-
cesses as well as creeping weight gain and progressive
development of insulin resistance [1]. In addition, the
prevalence of dyslipidemia increased with BMI in our
study, which was consistent with some previous studies
[1, 14, 32, 33]. The lipid abnormalities in overweight and
obesity is likely a consequence of insulin resistance [34].
The overweight and obesity prevalence in 2010 was
30.6 % and 12.0 %, which have increased by 34.21 % and
69.01 %, respectively, since 2002 [35, 36]. By compari-
son, we found that the prevalence of abnormal body
weight in Shenzhen was comparable with that in main-
land China as a whole [35]. The rapid development of
overweight or obesity in Shenzhen will undoubtedly ac-
celerate the prevalence of dyslipidemia.
Several well established risk factors for dyslipidemia,
including hypertension and diabetes have been evaluated
[1, 12, 14, 33, 37]. We found a consistent pattern of an
increasing prevalence of dyslipidemia with increasing
fasting blood glucose, and blood pressure. Several factors
are likely to be responsible for diabetic dyslipidemia: in-
sulin effects on liver apoprotein production, regulation
of lipoprotein lipase, actions of cholesteryl ester transfer
protein, and peripheral actions of insulin on adipose and
muscle [38]. Previous studies have demonstrated that
genetic factors may influence development of dyslipid-
emia hypertension, nongenetic, potentially modifiable
aspects of obesity are also closely related to expression
of this clinically important syndrome [39]. Given the rela-
tive high prevalence of dyslipidemia in patients with hyper-
tension or diabetes, it is imperative that any patient with
hypertension or diabetes be screened for dyslipidemia.
Other researchers observed associations between dys-
lipidemia and smoking [11, 40, 41]. Our results also
showed that smoking status of the participants was re-
lated to the prevalence of dyslipidemia. Concentrations
of TG in current smokers were shown to be significantly
higher and concentrations of HDL-C lower than those
who had never smoked or had stopped smoking [41].
Chitra et al. reported the presence of carbon monoxide
and nicotine content in the cigarette smoke, which de-
creases the activity of lipoprotein lipase resulted in the
elevated levels of triglycerides [42].
Potential limitations of our study should be men-
tioned. First, no dietary intake was measured. Therefore,
Ni et al. Lipids in Health and Disease  (2015) 14:71 Page 10 of 11our study cannot show their effect on serum lipids. Sec-
ond, potential recalled sources of bias including recall
bias and self-reported information. Finally, other risk
factors (such as stress, genetic factors) were not taken
into account.
Conclusions
Dyslipidemia was present in about 34.64 % of the study
population in Shenzhen, and the awareness rate of dys-
lipidemia was 25.04 %. Risk factors associated with dys-
lipidemia were aging, higher body size, hypertension,
diabetes, and smoking. Dyslipidemia is becoming an im-
portant public health problem. Obesity can be used to
screen for dyslipidemia along with other coexisting risk
factors such as hypertension and diabetes. There is an
urgent need to institute more positive public health
measures and screening programs and to treat patients
diagnosed with dyslipidemia.
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